EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dysfunctional high-density lipoprotein predicts survival, renal recovery and the need for kidney replacement therapy in acute kidney injury

Nikolaos Pagonas, Oliver Pfeifer iD, Stefan Erfurt iD, Meike Hoffmeister, Oliver Ritter, Theodoros Kelesidis, Daniel Patschan iD

Journal of Circulating Biomarkers · 17.03.2026 · 15 (1) · 16-27

DOI: 10.33393/jcb.2026.3584 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Circulating Biomarkers, online erschienen am 17.03.2026. Verfasst von Nikolaos Pagonas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine - Cardiology, Neuruppin University Hospital, Brandenburg Medical School (Theodor Fontane), Neuruppin - Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

There is growing evidence that oxidative stress contributes not only to the pathophysiology of atherosclerosis but also to acute kidney injury (AKI). This study investigated the prognostic value of nHDLox (normalized high-density lipoprotein with reduced antioxidant function) in hospitalized patients with AKI.Methods: nHDLox was measured within 48 hours of AKI diagnosis. We assessed its performance in predicting thefollowing primary endpoints: in-hospital all-cause mortality, need for kidney replacement therapy (KRT), andrestoration of kidney function before discharge. Secondary endpoints included clinical markers of severe diseasecourse: intensive care treatment, ventilatory support, and vasopressor requirement.

Results

Among 132 participants, 16.7% died in the hospital, 36.4% required KRT, and 31.1% had no restorationof kidney function. For all primary endpoints, nHDLox levels were significantly higher in non-survivors (2.00 vs.1.26; +58.7%; p = 0.009), in patients requiring KRT (1.66 vs. 1.23; +34.9%; p = 0.002), and in those without renalrecovery (1.71 vs. 1.23; +39.0%; p = 0.001). nHDLox was independently associated with death, KRT, and lack ofrenal recovery, with odds ratios for a twofold increase (95% CI) of 1.88 (1.19-2.98), 1.78 (1.17-2.69), and 2.09(1.34-3.26), respectively. Predictive performance was moderate, with AUC-ROC values (95% CI) of 0.68 (0.54-0.81),0.66 (0.56-0.76), and 0.67 (0.57-0.78). No differences were observed across secondary endpoints.

Conclusions

Impaired antioxidant HDL function is closely associated with clinically relevant AKI outcomes.nHDLox, therefore, represents a significant risk factor in both cardiovascular and kidney disease.

Schlagwörter

Stichwörter der Autor:innen

Acute Kidney InjuryDysfunctional HDLHDLoxKidney replacement therapyOxidized HDLRenal recovery

Autor:innen und Institutionen

  • Department of Internal Medicine - Cardiology, Neuruppin University Hospital, Brandenburg Medical School (Theodor Fontane), Neuruppin - Germany.
  • Faculty of Health Sciences (FGW), joint faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus - Germany.
  • Both authors contributed equally to the study.
  • Department of Internal Medicine I - Cardiology, Nephrology and Intensive Care Medicine, Brandenburg University Hospital, Brandenburg Medical School (Theodor Fontane), Brandenburg an der Havel - Germany.
  • Brandenburg Medical School Theodor Fontane, Institute of Biochemistry, Brandenburg an der Havel - Germany.
  • Department of Medicine, Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas - USA.

ORCID-Profile: Oliver Pfeifer, Stefan Erfurt, Daniel Patschan

Zitieren

APA

Pagonas, N., Pfeifer, O., Erfurt, S., Hoffmeister, M., Ritter, O., Kelesidis, T., & Patschan, D. (2026). Dysfunctional high-density lipoprotein predicts survival, renal recovery and the need for kidney replacement therapy in acute kidney injury. Journal of Circulating Biomarkers, 15(1), 16-27. https://doi.org/10.33393/jcb.2026.3584

Vancouver

Pagonas N, Pfeifer O, Erfurt S, Hoffmeister M, Ritter O, Kelesidis T, et al. Dysfunctional high-density lipoprotein predicts survival, renal recovery and the need for kidney replacement therapy in acute kidney injury. Journal of Circulating Biomarkers. 2026;15(1):16-27. doi:10.33393/jcb.2026.3584

BibTeX
@article{Pagonas2026,
  author = {Pagonas, Nikolaos and Pfeifer, Oliver and Erfurt, Stefan and Hoffmeister, Meike and Ritter, Oliver and Kelesidis, Theodoros and Patschan, Daniel},
  title = {Dysfunctional high-density lipoprotein predicts survival, renal recovery and the need for kidney replacement therapy in acute kidney injury},
  journal = {Journal of Circulating Biomarkers},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {16--27},
  doi = {10.33393/jcb.2026.3584}
}
Kostenlos starten →